BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35254597)

  • 1. MiR-139-5p/ENAH Affects Progression of Hepatocellular Carcinoma Cells.
    Zhang Y; Li M; Qiu Y; Wu Y; Chen S; Ni B; Tang D; Deng Z; Hu Z
    Biochem Genet; 2022 Dec; 60(6):2106-2119. PubMed ID: 35254597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1.
    Huang XP; Hou J; Shen XY; Huang CY; Zhang XH; Xie YA; Luo XL
    FEBS J; 2015 Feb; 282(3):579-94. PubMed ID: 25475121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
    Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
    Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-98-5p Inhibits Tumorigenesis of Hepatitis B Virus-Related Hepatocellular Carcinoma by Targeting NF-κB-Inducing Kinase.
    Fei X; Zhang P; Pan Y; Liu Y
    Yonsei Med J; 2020 Jun; 61(6):460-470. PubMed ID: 32469170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CircMTO1 suppresses hepatocellular carcinoma progression via the miR-541-5p/ZIC1 axis by regulating Wnt/β-catenin signaling pathway and epithelial-to-mesenchymal transition.
    Li D; Zhang J; Yang J; Wang J; Zhang R; Li J; Zhang R
    Cell Death Dis; 2021 Dec; 13(1):12. PubMed ID: 34930906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-769-5p contributes to the proliferation, migration and invasion of hepatocellular carcinoma cells by attenuating RYBP.
    Xian Y; Wang L; Yao B; Yang W; Mo H; Zhang L; Tu K
    Biomed Pharmacother; 2019 Oct; 118():109343. PubMed ID: 31545279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p.
    Lin XQ; Huang ZM; Chen X; Wu F; Wu W
    Yonsei Med J; 2018 Sep; 59(7):816-826. PubMed ID: 30091314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA MALAT1 mediates doxorubicin resistance of hepatocellular carcinoma by regulating miR-3129-5p/Nova1 axis.
    Cao Y; Zhang F; Wang H; Bi C; Cui J; Liu F; Pan H
    Mol Cell Biochem; 2021 Jan; 476(1):279-292. PubMed ID: 32965597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC.
    Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W
    BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA HCG11 accelerates the progression of hepatocellular carcinoma via miR-26a-5p/ATG12 axis.
    Li ML; Zhang Y; Ma LT
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10708-10720. PubMed ID: 31858580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-34a-5p plays an inhibitory role in hepatocellular carcinoma by regulating target gene VEGFA.
    Niu X; Wei N; Peng L; Li X; Zhang X; Wang C
    Malays J Pathol; 2022 Apr; 44(1):39-52. PubMed ID: 35484885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-548a-5p promotes proliferation and inhibits apoptosis in hepatocellular carcinoma cells by targeting Tg737.
    Zhao G; Wang T; Huang QK; Pu M; Sun W; Zhang ZC; Ling R; Tao KS
    World J Gastroenterol; 2016 Jun; 22(23):5364-73. PubMed ID: 27340352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-369-5p inhibits the proliferation and migration of hepatocellular carcinoma cells by down-regulating HOXA13 expression.
    Qian X; Wang Y; Hu W; Xu X; Gao L; Meng Y; Yan J
    Tissue Cell; 2022 Feb; 74():101721. PubMed ID: 34979376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0091579 Serves as a Tumor-Promoting Factor in Hepatocellular Carcinoma Through miR-1225-5p/PLCB1 Axis.
    Zhang D; Zhang Y; Zhang X; Zhai H; Sun X; Li Y
    Dig Dis Sci; 2022 Feb; 67(2):585-597. PubMed ID: 33559088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enabled homolog (ENAH) regulated by RNA binding protein splicing factor 3b subunit 4 (SF3B4) exacerbates the proliferation, invasion and migration of hepatocellular carcinoma cells via Notch signaling pathway.
    Deng G; Luo Y; Zhang Y; Zhang J; He Z
    Bioengineered; 2022 Feb; 13(2):2194-2206. PubMed ID: 35030977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma.
    Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.